Evaluation of the thromboembolic risk in patients with atrial fibrillation

dc.contributor.author	Turcan, Valeria
dc.date.accessioned	2020-07-06T11:11:05Z
dc.date.available	2020-07-06T11:11:05Z
dc.date.issued	2018
dc.identifier.citation	Valeria TURCAN. Evaluation of the thromboembolic risk in patients with atrial fibrillation. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 48-49.	en_US
dc.identifier.uri	https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf
dc.identifier.uri	http://repository.usmf.md/handle/20.500.12710/10999
dc.description	Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova	en_US
dc.description.abstract	Introduction. Atrial fibrillation (AF) is considered to be a new 21st-century epidemic, which by the end of 2060 shall affect an estimated 18 million people. More than 6 million Europeans suffer from AF, while in the United States AF is the cause of hospitalization of more than one third of the patients with heart rhythm disorders.	en_US
dc.language.iso	en	en_US
dc.publisher	MedEspera	en_US
dc.subject	atrial fibrillation	en_US
dc.subject	stroke	en_US
dc.subject	thromboembolism	en_US
dc.title	Evaluation of the thromboembolic risk in patients with atrial fibrillation	en_US
dc.type	Article	en_US